G. Giuffre et al., Standardized AgNOR analysis as a prognostic parameter in endometrial carcinoma, endometrioid type, ANAL QUAN C, 23(1), 2001, pp. 31-39
Citations number
55
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
OBJECTIVE: To evaluate interobserver,er reproducibility of histologic grade
in endometrial adenocarcinomas of endometrioid type (EC), to assess the re
lationships between nuclear grade and the amount of argyrophilic nucleolar
organizer region (AgNOR) proteins and to determine the prognostic value of
AgNOR proteins and the main clinicopathologic parameters.
STUDY DESIGN: Architectural and nuclear grading were independently assessed
by two pathologists in 64 formalin-fixed, paraffin-embedded surgical sampl
es of EC obtained from all equal number of patients (age range, 38-84 years
; mean, 63.5). Interobserver agreement was determined using the kappa stati
stic; discrepant cases were reviewed, and a consensus was reached. Standard
ized AgNOR analysis teas performed according to the guidelines of the Commi
ttee on AgNOR Quantification, measuring the mean area of AgNORs per nucleus
(NORA) by an image analysis system.
RESULTS: The kappa values for interobserver agreement were substantial for
architectural grading and moderate for nuclear grading. When NORA values we
re compared to the nuclear grade assessed by different observers, the most
significant linear correlation (r = .723, P < .001) was found for the nucle
ar assessment obtained by consensus of the two pathologists. Moreover, stat
istical analysis allowed discrimination of architectural grade 1 from grade
2 and 3 EC. By the Kaplan-Meier method, the prognosis was worse for patien
ts with higher NORA values (> 4.212 mum(2)), while, by Cox multivariate ana
lysis, AgNOR quantity emerged as an independent prognostic variable.
CONCLUSION: Use of standardized AgNOR analysis may be an additional and obj
ective tool in the assessment of histologic grade as well as a reliable met
hod of determining prognosis in EC.